0001567619-21-020429.txt : 20211115 0001567619-21-020429.hdr.sgml : 20211115 20211115161034 ACCESSION NUMBER: 0001567619-21-020429 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210930 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 EFFECTIVENESS DATE: 20211115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athyrium Capital Management, LP CENTRAL INDEX KEY: 0001728001 IRS NUMBER: 263965190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18509 FILM NUMBER: 211410603 BUSINESS ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-402-6925 MAIL ADDRESS: STREET 1: 505 FIFTH AVENUE, FLOOR 18 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001728001 XXXXXXXX 09-30-2021 09-30-2021 Athyrium Capital Management, LP
505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
13F HOLDINGS REPORT 028-18509 N
Andrew Hyman Chief Operating Officer and General Counsel 212-402-6925 /s/ Andrew Hyman New York NY 11-15-2021 0 5 157650 false
INFORMATION TABLE 2 form13fInfoTable.xml Progenity Inc. COM 74319F107 45381 29855847 SH SOLE NA 29855847 0 0 Progenity Inc. COM 74319F107 9942 6541060 SH OTR NA 0 6541060 0 Amryt Pharma PLC Sponsored ADS 03217L106 54443 4520000 SH SOLE NA 4520000 0 0 Recro Pharma Inc. COM 75629F109 4537 2202420 SH SOLE NA 2202420 0 0 CAREMAX INC COM CL A 14171W103 43347 4487220 SH SOLE NA 4487220 0 0